Back

Comparing biomarker profiles in patients with stable atherosclerosis treated with anacetrapib versus placebo: a nested proteomic study from HPS3/TIMI 55-REVEAL

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Acute coronary syndrome treatment Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor David Berg

Brigham and Women's Hospital, Boston (United States of America)

12 More presentations in this session

Presentation thumbnail
Strict versus no fasting prior to cardiac catheterization: a prospective evaluation of safety and clinical outcomes
Doctor A. Mishra (Sayre, US)
Abstract Slides
Presentation thumbnail
Intraventricular conduction disturbance and ventricular paced rhythms in patients with acute coronary syndromes
Doctor P. Azevedo (Faro, PT)
Abstract Slides
Presentation thumbnail
Reduced exercise capacity and clinical outcomes following acute myocardial infarction
Doctor H. Tashiro (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Ultrasound targeted delivery of exosomes derived from bone mesenchymal stem cells stimulate angiogenesis and reduce adverse remodeling after myocardial infarction
Doctor Q. Deng (Wuhan, CN)
Presentation thumbnail
Exercise training after acute coronary syndromes in the octogenarians has beneficial effect on the course of the disease and the exercise tolerance - single-center, prospective 12-months evaluation.
Professor R. Dabrowski (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Acute coronary syndrome treatment

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources